Efficacy of metformin on pregnancy complications in women with polycystic ovary syndrome: A meta-analysis

Gynecological Endocrinology

Volumn 31, Issue 11, 2015, Pages 833-839

  Feng, Li ^a   Lin, Xiao Fang ^a   Wan, Zhi Hua ^a   Hu, Dan ^a   Du, Yu Kai ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Metformin; miscarriage; polycystic ovary syndrome; pregnancy complications; premature birth

Indexed keywords

METFORMIN; ANTIDIABETIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INCIDENCE; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREMATURITY; PRIORITY JOURNAL; SCIENCEDIRECT; SPONTANEOUS ABORTION; ABORTION, SPONTANEOUS; CASE CONTROL STUDY; DIABETES, GESTATIONAL; POLYCYSTIC OVARY SYNDROME; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH;

ABORTION, SPONTANEOUS; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; METFORMIN; POLYCYSTIC OVARY SYNDROME; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH;

EID: 84949538131     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2015.1041906     Document Type: Article

References (45)

1. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007; 370: 685-97
2. Franks S. Polycystic ovary syndrome. New Engl J Med 1995; 333: 853-61
3. Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol 1999; 51: 779-86
4. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metabol 1999; 84: 4006-11
5. Asuncion M, Calvo RM, San Millan JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metabol 2000; 85: 2434-8
6. Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metabol 1998; 83: 3078-82
7. Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745-9
8. Tehrani FR, Simbar M, Tohidi M, et al. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: iranian PCOS prevalence study. Reprod Biol Endocrinol 2011; 9: 39
9. Chen X, Yang D, Mo Y, et al. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstetr Gynecol Reprod Biol 2008; 139: 59-64
10. Boomsma CM, Eijkemans M, Hughes EG, et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006; 12: 673-83
11. Qin JZ, Pang LH, Li MJ, et al. Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol 2013; 11: 56
12. Lord JM, Flight IH, Norman RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 2003; 327: 951
13. Palomba S, Falbo A, Orio FJ, Zullo F. Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 2009; 92: 1646-58
14. Romualdi D, De Cicco S, Gagliano D, et al. How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation. Diabetes Care 2013; 36: 1477-82
15. Ghazeeri GS, Nassar AH, Younes Z, Awwad JT. Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview. Acta Obstet Gynecol Scand 2012; 91: 658-78
16. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod (Oxford, England) 2004; 19: 41-7
17. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25
18. Thatcher SS, Jackson EM. Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin. Fertil Steril 2006; 85: 1002-9
19. Heard MJ, Pierce A, Carson SA, Buster JE. Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome. Fertil Steril 2002; 77: 669-73
20. Malik S, Katoch K, Allahbadia G. Outcome of second pregnancies when the first pregnancies were supported by metformin in patients of PCOS. In: Daya S, Pierson R, Gunby J, eds. International congress series;; 2004: 46-9
21. Sohrabvand F, Shariat M, Haghollahi F, Bagheri B. Effect of metformin on miscarriage in pregnant patients with polycystic ovary syndrome. West Indian Med J 2009; 58: 433-6
22. Morin-Papunen L, Rantala AS, Unkila-Kallio L, et al. Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J Clin Endocrinol Metab 2012; 97: 1492-500
23. Abd El Hameed AA, Shreif HE, Mowafy HE. The role of continuing metformin therapy during pregnancy in the reduction of gestational diabetes and improving pregnancy outcomes in women with polycystic ovary syndrome. Middle East Fertil Soc J 2011; 16: 204-8
24. Vanky E, Stridsklev S, Heimstad R, et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 2010; 95: E448-55
25. Vanky E, Salvesen KA, Heimstad R, et al. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 2004; 19: 1734-40
26. Khattab S, Mohsen IA, Foutouh IA, et al. Metformin reduces abortion in pregnant women with polycystic ovary syndrome. Gynecol Endocrinol 2006; 22: 680-4
27. Khattab S, Mohsen IA, Aboul FI, et al. Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study. Gynecol Endocrinol 2011; 27: 789-93
28. Begum MR, Khanam NN, Quadir E, et al. Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome. J Obstet Gynaecol Res 2009; 35: 282-6
29. Higgins J, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58
30. Wallace BC, Schmid CH, Lau J, Trikalinos TA. Meta-analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol 2009; 9: 80
31. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101
32. Glueck CJ, Phillips H, Cameron D, et al. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 2001; 75: 46-52
33. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, et al. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 524-9
34. Glueck CJ, Phillips H, Cameron D, et al. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 2001; 75: 46-52
35. Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002; 17: 2858-64
36. De Leo V, Musacchio MC, Piomboni P, et al. The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications. Eur J Obstet Gynecol Reprod Biol 2011; 157: 63-6
37. Nawaz FH, Khalid R, Naru T, Rizvi J. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome? J Obstet Gynaecol Res 2008; 34: 832-7
38. Glueck CJ, Bornovali S, Pranikoff J, et al. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome. Diabet Med 2004; 21: 829-36
39. Gezer A, Yalçiner EP, Güralp O, et al. Neonatal morbidity and mortality results in preterm premature rupture of membranes. Turk Pediatri Arsivi-Turkish Arch Pediatr 2011; 46: 296-301
40. Nour NM. Premature delivery and the millennium development goal. Rev Obstetr Gynecol 2012; 5: 100-5
41. Belizán JM, Hofmeyr J, Buekens P, et al. Preterm birth, an unresolved issue. Reprod Health 2013; 10: 58
42. Fianu S, Joelsson I. Minimal brain dysfunction in children born in breech presentation. Acta Obstetricia Et Gynecologica Scandinavica 1979; 58: 295-9
43. Kovo M, Weissman A, Gur D, et al. Neonatal outcome in polycystic ovarian syndrome patients treated with metformin during pregnancy. J Matern Fetal Neonatal Med 2006; 19: 415-19
44. Bolton S, Cleary B, Walsh J, et al. Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity. Eur J Pediatr 2009; 168: 203-6
45. Nawaz FH, Rizvi J. Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome. Gynecol Obstet Invest 2010; 69: 184-9